Sadanandam, AngurajLyssiotis, CostasHanahan, DouglasGray, Joe2017-05-242017-05-242017-05-242015https://infoscience.epfl.ch/handle/20.500.14299/137572The present invention relates to gene sets, the expression levels of which are useful for classifying colorectal tumors and predicting disease-free prognosis and response of patients to specific therapies that are either novel or currently available in the clinics for colorectal cancer patients.patentEP2922972US2015354009EP2922972CA2892757WO201408038150002795